17.12.2024 15:45:00

15 Billion Reasons to Love Eli Lilly Stock Right Now

Pharmaceutical giant Eli Lilly (NYSE: LLY) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two punch of blockbuster diabetes and obesity care medications, Mounjaro and Zepbound.The excitement surrounding the weight loss market has fueled a stock-buying frenzy, propelling Lilly to a market capitalization of roughly $720 billion -- making it the most valuable pharmaceutical company in the world.At first glance, you might think you've missed out and the train has already left the station. However, a recent announcement from the company suggests that notion is far from reality.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu Eli Lillymehr Analysen

31.10.24 Eli Lilly Buy Jefferies & Company Inc.
13.02.24 Eli Lilly Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Eli Lilly 743,50 0,73% Eli Lilly
NOW Inc When Issued 13,40 -0,74% NOW Inc When Issued